Status
Conditions
Treatments
About
The Kaihani Score is a blood based means of assessing molecules believed to be associated with gambling addiction.
The current clinical trial will assess the Kaihani Score in 3 groups:
Group 1: 10 patients with no personal or family problems with gambling as assessed by the PG-YBOCS (obsessions-compulsions scale Yale-Brown (Y-BOCS), adapted for pathological gambling) (PG-YBOCS).
Group 2: 10 patients with moderate gambling addiction as assessed by the PG-YBOCS (obsessions-compulsions scale Yale-Brown (Y-BOCS), adapted for pathological gambling) (PG-YBOCS).
Group 3: 10 patients with severe gambling addiction as assessed by the PG-YBOCS (obsessions-compulsions scale Yale-Brown (Y-BOCS), adapted for pathological gambling) (PG-YBOCS).
The goal of the study is to confirm preliminary efficacy of the Kaihani Score as a blood based means of assessing gambling propensity.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
30 participants in 3 patient groups
Loading...
Central trial contact
Wais Kaihani; Thomas Ichim, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal